Profile
Full Name
Nuvectis Pharma, Inc.Ticker Symbol
NVCTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 4, 2022Indexes
Not includedWebsite
http://www.nuvectis.comEmployees
13Key Details
Price
$8.70(-8.71%)
Market cap
$203.51M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.11(+22.38% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Nuvectis Pharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 2, 25 Maxim Group
BuyMar 17, 25 Laidlaw & Co.
BuyFeb 25, 25 HC Wainwright & Co.
BuyAug 6, 24 HC Wainwright & Co.
BuyMay 8, 24 HC Wainwright & Co.
BuySep 15, 23 HC Wainwright & Co.
BuyMar 7, 23 HC Wainwright & Co.
BuyFeb 10, 23 HC Wainwright & Co.
BuyJul 13, 22 Ladenburg Thalmann
BuyMay 10, 22 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Nuvectis Pharma?
- Does Nuvectis Pharma pay dividends?
- What sector is Nuvectis Pharma in?
- What industry is Nuvectis Pharma in?
- What country is Nuvectis Pharma based in?
- When did Nuvectis Pharma go public?
- Is Nuvectis Pharma in the S&P 500?
- Is Nuvectis Pharma in the NASDAQ 100?
- Is Nuvectis Pharma in the Dow Jones?
- When was Nuvectis Pharma's last earnings report?
- When does Nuvectis Pharma report earnings?
- Should I buy Nuvectis Pharma stock now?
What is the ticker symbol for Nuvectis Pharma?
The ticker symbol for Nuvectis Pharma is NASDAQ:NVCT
Does Nuvectis Pharma pay dividends?
No, Nuvectis Pharma does not pay dividends
What sector is Nuvectis Pharma in?
Nuvectis Pharma is in the Healthcare sector
What industry is Nuvectis Pharma in?
Nuvectis Pharma is in the Biotechnology industry
What country is Nuvectis Pharma based in?
Nuvectis Pharma is headquartered in United States
When did Nuvectis Pharma go public?
Nuvectis Pharma's initial public offering (IPO) was on February 4, 2022
Is Nuvectis Pharma in the S&P 500?
No, Nuvectis Pharma is not included in the S&P 500 index
Is Nuvectis Pharma in the NASDAQ 100?
No, Nuvectis Pharma is not included in the NASDAQ 100 index
Is Nuvectis Pharma in the Dow Jones?
No, Nuvectis Pharma is not included in the Dow Jones index
When was Nuvectis Pharma's last earnings report?
Nuvectis Pharma's most recent earnings report was on Nov 5, 2024
When does Nuvectis Pharma report earnings?
The next expected earnings date for Nuvectis Pharma is May 7, 2025
Should I buy Nuvectis Pharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions